Medical Condition

peripheral arterial disease

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 4, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for peripheral arterial disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — peripheral arterial disease Clinical Trials

How many clinical trials are currently recruiting for peripheral arterial disease?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for peripheral arterial disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for peripheral arterial disease?

peripheral arterial disease research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a peripheral arterial disease clinical trial?

Eligibility criteria for peripheral arterial disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Phase 3

Phase 4

Top Sponsors

Northwestern University 2 trials

Rebecka Hultgren 1 trial

University of Virginia 1 trial

Clinical Centre of Serbia 1 trial

IRCCS Azienda Ospedaliero-Universitaria di Bologna 1 trial

Recruiting Clinical Trials

NCT04188808

Recruiting

Prospective Case-control Study in Patients With PAA

Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status

University of Virginia

View Trial →

NCT06253312

Recruiting

Treatment of TASC C and D Aortoiliac Lesions

Clinical Centre of Serbia

View Trial →

NCT06806540

Recruiting

The Frequency of Peripheral Arterial Disease in Patients with Deep Vein Thrombosis of the Lower Limbs

IRCCS Azienda Ospedaliero-Univ...

View Trial →

NCT06873321 Phase 4

Recruiting

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Science Valley Research Instit...

View Trial →

NCT06399809 Phase 2

Recruiting

Fisetin to Reduce Senescence and Mobility Impairment in PAD

Northwestern University

View Trial →

NCT06032065 Phase 3

Recruiting

SMART Exercise for PAD

Northwestern University

View Trial →

NCT05854641 Phase 4

Recruiting

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease

Cell Biopeutics Resources Sdn ...

View Trial →

NCT07223437

Recruiting

REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center

University of Tennessee Gradua...

View Trial →

NCT05894863

Recruiting

Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions

A ProspeCtive mUlticenteR Investigation on RENzar Stent Safety and Efficacy in the Treatment of Patients With Femoro-popliteal Disease in Tuscany (CURRENT Registry)

Azienda Ospedaliera Universita...

View Trial →

NCT02280733

Recruiting

A Real-World Registry of Chronic Wounds and Ulcers

Related Conditions

aging (2) peripheral vascular diseases (2) walking difficulty (2) popliteal artery aneurysm (1) quality of life (1) heart failure systolic (1) heart failure diastolic (1) overweight and obesity (1) aortoiliac occlusive disease (1) leriche syndrome (1) peripheral vascular disease (1) thromboembolism (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology